Formononetin
Especificaciones
485-72-3Número CAS
207-623-9Número CE
7-hydroxy-3-(4-methoxyphenyl)chromen-4-oneNombre IUPAC
C16H12O4Fórmula química
268.26 g/molPeso molecular
formononetin; 485-72-3; Biochanin B; Formononetol; 7-Hydroxy-4'-methoxyisoflavone; 7-hydroxy-3-(4-methoxyphenyl)chromen-4-one; Flavosil; Myconate; Neochanin; Mycotech; 4'-O-methyldaidzein; DTXSID4022311; NSC-93360; 295DQC67BJ; CHEBI:18088; 7-hydroxy-4'-methoxy-isoflavone; DTXCID502311; RefChem:5842; 207-623-9; 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-; 7-Hydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one; MFCD00016948; Isoflavone, 7-hydroxy-4'-methoxy-; 7-Hydroxy-3-(4-methoxyphenyl)-4-benzopyrone; 7-Hydroxy-3-(4-methoxyphenyl)chromone; NSC93360; Neochanin; Flavosil;NEOCHANIN;Formononetol; 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one; Fermononetin; SMR000470932; SR-01000765510; EINECS 207-623-9; NSC 93360; formononetine; UNII-295DQC67BJ; Formoononetin;; Neochanin;; Biochanin B;; Formononetin (FOR); Spectrum_000373; Formononetin (Standard); SpecPlus_000223; Daidzein 4-methyl ether; Spectrum2_000560; Spectrum3_000660; Spectrum4_001429; Spectrum5_000258; FORMONONETIN [MI]; NCIOpen2_005983; Oprea1_139748; Oprea1_815287; SCHEMBL62915; BSPBio_002299; KBioGR_001878; KBioSS_000853; SPECTRUM102007; MLS000697593; MLS006011897; BIDD:ER0119; DivK1c_006319; FORMONONETIN [USP-RS]; SPBio_000639; CHEMBL242341; orb1224969; orb1310347; orb3140356; SCHEMBL29361145; Formononetin, analytical standard; HY-N0183R; KBio1_001263; KBio2_000853; KBio2_003421; KBio2_005989; KBio3_001519; HMS1922N18; HMS2231I04; HMS3369C07; HMS3655N22; HMS5080N06; ALBB-030789; Formononetin, >=99.0% (TLC); HY-N0183; MSK40259; TNP00176; Tox21_301848; BBL010458; BDBM50021398; CCG-38727; EBC-00591; LMPK12050037; s2299; SBB016445; STK801612; AKOS000270811; AC-8001; DB15335; FF09317; SDCCGMLS-0066428.P001; 7-hydroxy-4'-methoxy-Isoflavone (8CI); NCGC00017269-01; NCGC00017269-02; NCGC00017269-03; NCGC00017269-04; NCGC00017269-05; NCGC00017269-06; NCGC00017269-07; NCGC00017269-09; NCGC00095207-01; NCGC00095207-02; NCGC00095207-03; NCGC00178715-01; NCGC00255167-01; AS-11642; CAS-485-72-3; NCI60_042081; ST024713; F0868; F5770; K-080; NS00002004; SW219915-1; C00858; EN300-116214; AB00052676-07; AC-542/21092001; AE-641/01968055; F235653; Q408859; SR-01000765510-3; SR-01000765510-4; BRD-K55567017-001-02-4; BRD-K55567017-001-06-5; BRD-K55567017-001-12-3; FORMONONETIN (CONSTITUENT OF ASTRAGALUS) [DSC]; FORMONONETIN (CONSTITUENT OF RED CLOVER) [DSC]; F3139-1207; Z374511822; 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one(9CI); Formononetin, United States Pharmacopeia (USP) Reference StandardSinónimos